The advice represents a significant shift in practice and results in a substantial additional workload for ophthalmology services to undertake and interpret retinal imaging. In follow up to the BSR guidelines, and in response to the recognition of the increasing number of patients identified with advanced HCQ retinopathy [2, 3], the Royal College of Ophthalmologists (RCOphth) have now published their own, more detailed, recommendations; these provide additional clarity to the BSR guidelines regarding the diagnostic tests required and suggested monitoring schedules . Plaquenil not working what next Hydroxychloroquine sulfate rheumatoid arthritis The Royal College of Ophthalmologists has issued updated guidance for monitoring for hydroxychloroquine retinopathy. The new guidance requires a consultant-led service. The CCG is working towards commissioning a service in Devon and will issue an updated shared care guideline when the service is in place. The Royal College of Ophthalmologists RCOpth published guidance on hydroxychloroquine and chloroquine retinopathy screening in 2018. The guidance recommends that all patients planning to take hydroxychloroquine long term i.e. more than five years should have an OCT scan within 12 months preferably within six months of starting therapy and annual screening following five years of treatment. The Royal College of Ophthalmologists has released its latest guidelines for Screening and Management of Hydroxychloroquine Retinopathy. Retinopathy caused by hydroxychloroquine is very common and its prevalence in long-term use patients appears to be around 7.5% and depending on dose and duration of therapy can increase to 20-50% after 20 years of therapy. During treatment, it recommends ‘annual eye assessment (ideally including optical coherence tomography) if treatment is continued for 5 years’ . The current BSR guidelines state ‘Patients should have baseline formal ophthalmic examination, ideally including objective retinal assessment for example using optical coherence tomography, within 1 year of commencing an antimalarial drug’ . Royal college of ophthalmologists hydroxychloroquine Hydroxychloroquine and Retinal Screening, Statement hydroxychloroquine and chloroquine retinopathy screening. Hydroxychloroquine cure headaches This will have implications for service provision. Updated guidance from the Royal College of Ophthalmologists is currently in consultation phase. Funding No specific funding was received from any bodies in the public, commercial or not-for-profit sectors to carry out the work described in this manuscript. Hydroxychloroquine-induced retinal toxicity in an.. RCO Guidelines for Screening and Management of.. How to set up a Hydroxychloroquine Retinopathy Screening.. Jun 11, 2018 The Royal College of Ophthalmologists recently published recommendations for retinal screening in users of hydroxychloroquine and chloroquine in the United Kingdom 1. This article forms a. The guidance was developed by a guideline working party GWP from the Royal College of Ophthalmologists RCOphth and the Royal College of Paediatrics and Child Health RCPCH. It brings together previous publications of the RCO and an update of the literature since these publications. Screening may not “prevent” damage, but if conducted properly it enables the detection of toxicity before vision is significantly affected. The Royal College of Ophthalmologists published guidelines on “Hydroxychloroquine and Chloroquine Retinopathy Recommendations on Screening” in February 2018.